[go: up one dir, main page]

NZ286432A - Pharmaceutical compositions comprising 3-substituted-2-oxoindole-carboxamide derivatives and method of inhibition by photodecomposition thereof - Google Patents

Pharmaceutical compositions comprising 3-substituted-2-oxoindole-carboxamide derivatives and method of inhibition by photodecomposition thereof

Info

Publication number
NZ286432A
NZ286432A NZ286432A NZ28643296A NZ286432A NZ 286432 A NZ286432 A NZ 286432A NZ 286432 A NZ286432 A NZ 286432A NZ 28643296 A NZ28643296 A NZ 28643296A NZ 286432 A NZ286432 A NZ 286432A
Authority
NZ
New Zealand
Prior art keywords
red
compound
light
yellow
lake
Prior art date
Application number
NZ286432A
Other languages
English (en)
Inventor
Willard C Newlin
Sharon M Laughlin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NZ286432A publication Critical patent/NZ286432A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Polymerisation Methods In General (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ286432A 1995-04-24 1996-04-23 Pharmaceutical compositions comprising 3-substituted-2-oxoindole-carboxamide derivatives and method of inhibition by photodecomposition thereof NZ286432A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000287 WO1996033701A1 (en) 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles

Publications (1)

Publication Number Publication Date
NZ286432A true NZ286432A (en) 1998-05-27

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ286432A NZ286432A (en) 1995-04-24 1996-04-23 Pharmaceutical compositions comprising 3-substituted-2-oxoindole-carboxamide derivatives and method of inhibition by photodecomposition thereof

Country Status (30)

Country Link
EP (1) EP0827399A1 (es)
JP (1) JPH10506635A (es)
KR (1) KR100189585B1 (es)
CN (1) CN1053667C (es)
AP (1) AP607A (es)
AR (1) AR002728A1 (es)
AU (1) AU692378B2 (es)
BG (1) BG100531A (es)
BR (1) BR9602024A (es)
CO (1) CO4700418A1 (es)
FI (1) FI973988L (es)
HR (1) HRP960194A2 (es)
HU (1) HU216544B (es)
IL (1) IL117969A0 (es)
IS (1) IS4339A (es)
MA (1) MA23848A1 (es)
NO (1) NO961622L (es)
NZ (1) NZ286432A (es)
OA (1) OA10286A (es)
PE (1) PE34397A1 (es)
RO (1) RO113305B1 (es)
RU (1) RU2109510C1 (es)
SG (1) SG64924A1 (es)
SI (1) SI9600133A (es)
SK (1) SK51296A3 (es)
TR (1) TR199600300A2 (es)
UA (1) UA42739C2 (es)
WO (1) WO1996033701A1 (es)
YU (1) YU25096A (es)
ZA (1) ZA963210B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019132959A1 (en) 2017-12-29 2019-07-04 Kraft Foods Group Brands Llc Improved oxidative stability of oil-in-water emulsions using natural stabilizers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3136282A1 (de) * 1981-09-12 1983-03-24 Hoechst Ag "verfahren zur stabilisierung photoinstabiler arzneistoffe sowie stabilisierte arzneizubereitungen"
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
RO113305B1 (ro) 1998-06-30
OA10286A (en) 1997-09-19
JPH10506635A (ja) 1998-06-30
MA23848A1 (fr) 1996-12-31
NO961622D0 (no) 1996-04-23
FI973988A0 (fi) 1997-10-17
FI973988A7 (fi) 1997-10-17
CO4700418A1 (es) 1998-12-29
WO1996033701A1 (en) 1996-10-31
UA42739C2 (uk) 2001-11-15
KR960037656A (ko) 1996-11-19
AP9600787A0 (en) 1996-04-30
HUP9601057A3 (en) 1997-05-28
PE34397A1 (es) 1997-09-29
YU25096A (sh) 1998-08-14
ZA963210B (en) 1997-10-23
AU692378B2 (en) 1998-06-04
EP0827399A1 (en) 1998-03-11
HUP9601057A2 (en) 1997-04-28
AU5085196A (en) 1996-11-07
FI973988L (fi) 1997-10-17
BG100531A (bg) 1997-06-30
CN1139110A (zh) 1997-01-01
SG64924A1 (en) 1999-05-25
NO961622L (no) 1996-10-25
AP607A (en) 1997-08-27
RU2109510C1 (ru) 1998-04-27
BR9602024A (pt) 1998-10-06
AR002728A1 (es) 1998-04-29
CN1053667C (zh) 2000-06-21
SK51296A3 (en) 1997-04-09
TR199600300A2 (tr) 1996-11-21
IL117969A0 (en) 1996-08-04
HU216544B (hu) 1999-07-28
KR100189585B1 (ko) 1999-06-01
SI9600133A (en) 1996-10-31
HU9601057D0 (en) 1996-06-28
HRP960194A2 (en) 1998-02-28
IS4339A (is) 1996-10-25

Similar Documents

Publication Publication Date Title
FI92904C (fi) Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
AU681236B2 (en) Sustained-release dosage forms of alfuzosin hydrochloride
KR930003905A (ko) 약학적 결합 제제
US4929605A (en) Pharmaceutical composition for piperidinoalkanol derivatives
KR100397082B1 (ko) 이부프로펜및코데인을함유하는약제제형
RU96118271A (ru) Композиции, содержащие тонкоизмельченный небиволол
US3652762A (en) Pharmaceutical compositions and methods employing substituted derivatives of 2-anilinophenylacetic acids and esters
CA1300509C (en) Pharmaceutical compositions for relief of dysmenorrhea and/orpremenstrual syndrome and process
NL8600302A (nl) Farmaceutische preparaten met analgetische werkzaamheid, alsmede de bereiding en toepassing ervan.
NO303669B1 (no) FremgangsmÕte for fremstilling av en tablett eller dragÚpreparat
NZ286432A (en) Pharmaceutical compositions comprising 3-substituted-2-oxoindole-carboxamide derivatives and method of inhibition by photodecomposition thereof
US5290774A (en) Photostabilizing method for ophthalmic solutions and the resulting ophthalmic solutions therefrom
US4188393A (en) Treating spastic conditions or relaxing muscles
CA2216931A1 (en) Inhibiting photodecomposition of 3-substituted-2-oxindoles
HU9301846D0 (en) Method for producing biphenylyl-quinuclidine compounds and medical preparatives containing them as active agent
WO2018033483A1 (en) Pharmaceutical compositions of a benzothiophene compound
ZA200006465B (en) Novel formulation containing paroxetine.
CA2331871A1 (en) Novel formulation containing paroxetine
PL186975B1 (pl) Zastosowanie 2-metylo-4-{4-metylo-1-piperazynylo}-10H-tieno[2,3-b] [1,5]benzodiazepiny
RU96108120A (ru) Способ ингибирования, таблетка и капсула
MXPA00004573A (es) Forma de dosis oral novedosa para carvedilol
MXPA00011153A (es) Nueva formulacion que contiene paroxetina
CZ20004185A3 (cs) Nový prostředek obsahující paroxetin